Vesalius BioCapital Partners invests in companies active in human health through venture capital funds raised.
Phone:
1B rue Thomas Edison
L-1445
Luxembourg
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-11-10 | Catalym | Series B | $59.06M | Bayern Kapital, BioGeneration Ventures, Coparion, Forbion Capital Partners, and Novartis Venture Funds |
2020-10-19 | Topas Therapeutics | Series B | $25.92M | BioMedPartners |
2020-02-27 | SWORD Health | Series A - II | $9M | Faber Ventures, Founders Fund, Green Innovations, Khosla Ventures, and Lachy Groom |
2020-02-14 | OncoDNA | Series B - II | $14.31M | Ackermans & Van Haaren, Banque CPH, Inventures, investiere, La Société Fédérale de Participations et d'Investissement, Sambrinvest, Société Régionale d'Investissement de Wallonie, and Swisscanto Invest |
2020-01-15 | Mecuris | Series A - II | $4.01M | Bayern Kapital, High-Tech Grunderfonds, Mulcan International Investments, and Sana Kliniken |